Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone
The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the preparation of a drug for treating peripheral T-cell lymphoma (PTCL). The PTCL is preferably naïve PTCL. Other first-line and second-line drugs for treating PTCL may also be further used on the b...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JIA, Runlu LI, Tong WANG, Shixia LI, Chunlei XIA, Xuefang DU, Yanling AN, Na LI, Yanhui |
| description | The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the preparation of a drug for treating peripheral T-cell lymphoma (PTCL). The PTCL is preferably naïve PTCL. Other first-line and second-line drugs for treating PTCL may also be further used on the basis of the foregoing. A method for treating PTCL, the method comprising administering, to a patient, a therapeutically effective amount of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone. The combined administration of the drugs is safe and tolerable, has a small toxicity and few side effects, and can obtain a higher total objective remission rate (ORR) in naïve PTCL patients. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021334710BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021334710BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021334710BB23</originalsourceid><addsrcrecordid>eNqNjDsKwkAQQNNYiHqHKSwV8hFSG1E8gKkswrI7YQc2M8vOIub2BvQAVq94j7cunr0iyAgTZXkbzkkYwc8uifVBEjmEQFFUJgTDDuxsg0QvGr2ZFnuAF7FNpJn4W8SEjkmXz7ZYjSYo7n7cFPvb9XG5HzHKgBqNRcY8nPu6rKumObVV2XV182f2AWTxPc8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone</title><source>esp@cenet</source><creator>JIA, Runlu ; LI, Tong ; WANG, Shixia ; LI, Chunlei ; XIA, Xuefang ; DU, Yanling ; AN, Na ; LI, Yanhui</creator><creatorcontrib>JIA, Runlu ; LI, Tong ; WANG, Shixia ; LI, Chunlei ; XIA, Xuefang ; DU, Yanling ; AN, Na ; LI, Yanhui</creatorcontrib><description>The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the preparation of a drug for treating peripheral T-cell lymphoma (PTCL). The PTCL is preferably naïve PTCL. Other first-line and second-line drugs for treating PTCL may also be further used on the basis of the foregoing. A method for treating PTCL, the method comprising administering, to a patient, a therapeutically effective amount of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone. The combined administration of the drugs is safe and tolerable, has a small toxicity and few side effects, and can obtain a higher total objective remission rate (ORR) in naïve PTCL patients.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241024&DB=EPODOC&CC=AU&NR=2021334710B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241024&DB=EPODOC&CC=AU&NR=2021334710B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JIA, Runlu</creatorcontrib><creatorcontrib>LI, Tong</creatorcontrib><creatorcontrib>WANG, Shixia</creatorcontrib><creatorcontrib>LI, Chunlei</creatorcontrib><creatorcontrib>XIA, Xuefang</creatorcontrib><creatorcontrib>DU, Yanling</creatorcontrib><creatorcontrib>AN, Na</creatorcontrib><creatorcontrib>LI, Yanhui</creatorcontrib><title>Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone</title><description>The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the preparation of a drug for treating peripheral T-cell lymphoma (PTCL). The PTCL is preferably naïve PTCL. Other first-line and second-line drugs for treating PTCL may also be further used on the basis of the foregoing. A method for treating PTCL, the method comprising administering, to a patient, a therapeutically effective amount of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone. The combined administration of the drugs is safe and tolerable, has a small toxicity and few side effects, and can obtain a higher total objective remission rate (ORR) in naïve PTCL patients.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDsKwkAQQNNYiHqHKSwV8hFSG1E8gKkswrI7YQc2M8vOIub2BvQAVq94j7cunr0iyAgTZXkbzkkYwc8uifVBEjmEQFFUJgTDDuxsg0QvGr2ZFnuAF7FNpJn4W8SEjkmXz7ZYjSYo7n7cFPvb9XG5HzHKgBqNRcY8nPu6rKumObVV2XV182f2AWTxPc8</recordid><startdate>20241024</startdate><enddate>20241024</enddate><creator>JIA, Runlu</creator><creator>LI, Tong</creator><creator>WANG, Shixia</creator><creator>LI, Chunlei</creator><creator>XIA, Xuefang</creator><creator>DU, Yanling</creator><creator>AN, Na</creator><creator>LI, Yanhui</creator><scope>EVB</scope></search><sort><creationdate>20241024</creationdate><title>Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone</title><author>JIA, Runlu ; LI, Tong ; WANG, Shixia ; LI, Chunlei ; XIA, Xuefang ; DU, Yanling ; AN, Na ; LI, Yanhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021334710BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JIA, Runlu</creatorcontrib><creatorcontrib>LI, Tong</creatorcontrib><creatorcontrib>WANG, Shixia</creatorcontrib><creatorcontrib>LI, Chunlei</creatorcontrib><creatorcontrib>XIA, Xuefang</creatorcontrib><creatorcontrib>DU, Yanling</creatorcontrib><creatorcontrib>AN, Na</creatorcontrib><creatorcontrib>LI, Yanhui</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JIA, Runlu</au><au>LI, Tong</au><au>WANG, Shixia</au><au>LI, Chunlei</au><au>XIA, Xuefang</au><au>DU, Yanling</au><au>AN, Na</au><au>LI, Yanhui</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone</title><date>2024-10-24</date><risdate>2024</risdate><abstract>The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the preparation of a drug for treating peripheral T-cell lymphoma (PTCL). The PTCL is preferably naïve PTCL. Other first-line and second-line drugs for treating PTCL may also be further used on the basis of the foregoing. A method for treating PTCL, the method comprising administering, to a patient, a therapeutically effective amount of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone. The combined administration of the drugs is safe and tolerable, has a small toxicity and few side effects, and can obtain a higher total objective remission rate (ORR) in naïve PTCL patients.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2021334710BB2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JIA,%20Runlu&rft.date=2024-10-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021334710BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |